Related Experiment Video
Updated: Jun 7, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected
A D Raymond1, T C Campbell-Sims, M Khan
1Morehouse School of Medicine, Atlanta, Georgia 30310, USA.
Abstract:
HIV-1 Nef has been demonstrated to be integral for viral persistence, infectivity, and the acceleration of disease pathogenesis (AIDS) in humans. Nef has also been detected in the plasma of HIV-infected individuals and is released from infected cells. The form in which Nef is released from infected cells is unknown. However, Nef is a myristoylated protein and has been shown to interact with the intracellular vesicular trafficking network. Here we show that Nef is released in CD45-containing microvesicles. This microvesicular Nef (mvNef) is detected in the plasma of HIV-infected individuals at relatively high concentrations (10 ng/ml). It is also present in tissue culture supernatants of Jurkat cells infected with HIV(MN). Interestingly, plasma mvNef levels in HIV(+) patients did not significantly correlate with viral load or CD4 count. Microvesicular Nef levels persisted in the plasma of HIV-infected individuals despite the use of antiretroviral therapy, even in individuals with undetectable viral loads. Using cell lines, we found Nef microvesicles induce apoptosis in Jurkat T-lymphocytes but had no observed effect on the U937 monocytic cell line. Given the large amount of mvNef present in the plasma of HIV-infected individuals, the apoptotic effect of mvNef on T cells, and the observed functions of extracellular soluble Nef in vitro, it seems likely that in vivo mvNef may play a significant role in the pathogenesis of AIDS.
Insights
Human immunodeficiency virus type 1 Nef protein is released from infected cells within microvesicles. This microvesicular Nef (mvNef) is found in patient plasma and induces T-cell apoptosis, potentially contributing to AIDS pathogenesis.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) Nef protein is crucial for viral persistence, infectivity, and AIDS progression.
- Nef is detected in plasma and released from infected cells, but its release form was unknown.
- Nef is a myristoylated protein interacting with intracellular vesicular trafficking.
Purpose of the Study:
- To determine the form in which HIV-1 Nef is released from infected cells.
- To investigate the presence and characteristics of extracellular Nef in HIV-infected individuals.
- To assess the biological activity of extracellular Nef on immune cells.
Main Methods:
- Detection and quantification of Nef in microvesicles from infected cell cultures and patient plasma.
- Analysis of microvesicular Nef (mvNef) levels in relation to viral load and CD4 count.
- Assessment of the effect of mvNef on Jurkat T-lymphocytes and U937 monocytic cells.
Main Results:
- HIV-1 Nef is released within CD45-containing microvesicles (mvNef).
- mvNef is present at high concentrations (10 ng/ml) in the plasma of HIV-infected individuals.
- Plasma mvNef levels did not correlate with viral load or CD4 count and persisted despite antiretroviral therapy.
- Nef microvesicles induced apoptosis in Jurkat T-lymphocytes but not U937 cells.
Conclusions:
- HIV-1 Nef is released extracellularly in microvesicles (mvNef).
- mvNef is abundant in HIV-infected individuals' plasma and resistant to antiretroviral therapy.
- mvNef's ability to induce T-cell apoptosis suggests a significant role in AIDS pathogenesis.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Intralumenal Vesicles and Multivesicular Bodies
Retrovirus Life Cycles
Influenza
Inhibitors Of Virion Release
Size and Structure of Viral Genomes

